Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PET Imaging of Subjects Using 124I-PU-AD: A Pilot Study

NCT03371420 is registered in ClinicalTrials.gov with Samus Therapeutics, Inc. as lead sponsor.

NCT NCT03371420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03371420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PET Imaging of Subjects Using 124I-PU-AD: A Pilot Study
Lead sponsor
Samus Therapeutics, Inc.
Phase
Phase 1
Overall status
Terminated
Start date
April 30, 2016
Completion date
June 10, 2019
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, lymphoma, myeloma, solid malignancy